Gut Microbiota Composition Before and After Use of Proton Pump Inhibitors
Open accessThe DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Recently, problems associated with proton pump inhibitor (PPI) use have begun to surface. PPIs influence the gut microbiota; therefore, PPI use may increase the risk of enteric infections and cause bacterial translocation. In this study, we investigated fecal microbiota composition, fecal organic acid concentrations and pH, and gut bacteria in the blood of the same patients before and after PPI use. METHODS: Twenty patients with reflux esophagitis based on endoscopic examination received 8 weeks of treatment with PPIs. To analyze fecal microbiota composition and gut bacteria in blood and organic acid concentrations, 16S and 23S rRNA-targeted quantitative RT-PCR and high-performance liquid chromatography were conducted. RESULTS: Lactobacillus species were significantly increased at both 4 and 8 weeks after PPI treatment compared with bacterial counts before treatment (P = 0.011 and P = 0.002, respectively). Among Lactobacillus spp., counts of the L. gasseri subgroup, L. fermentum, the L. reuteri subgroup, and the L. ruminis subgroup were significantly increased at 4 and 8 weeks after treatment compared with counts before treatment. Streptococcus species were also significantly increased at 4 and 8 weeks after PPI treatment compared with counts before treatment (P < 0.01 and P < 0.001, respectively). There was no significant difference in the total organic acid concentrations before and after PPI treatment. Detection rates of bacteria in blood before and after PPI treatment were 22 and 28%, respectively, with no significant differences. CONCLUSIONS: Our quantitative RT-PCR results showed that gut dysbiosis was caused by PPI use, corroborating previous results obtained by metagenomic analysis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Of note, antibiotics (except vancomycin),4”
From Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome (2024) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
A metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762
Lundell, L. R., Dent, J., Bennett, J. R., Blum, A. L., Armstrong, D., Galmiche, J. P., Johnson, F., Hongo, M., Richter, J. E., Spechler, S. J., et al. (1999) · Gut · doi:10.1136/gut.45.2.172 · Cited by 2,305
Control of pathogens and pathobionts by the gut microbiota
Kamada, N., Chen, G. Y., Inohara, N., & Núñez, G. (2013) · Nature Immunology · doi:10.1038/ni.2608 · Cited by 1,625
Proton pump inhibitors affect the gut microbiome
Imhann, F., Bonder, M. J., Vich Vila, A., Fu, J., Mujagic, Z., Vork, L., Tigchelaar, E. F., Jankipersadsing, S. A., Cenit, M. C., Harmsen, H. J. M., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310376 · Cited by 1,371 · cited 14×
“Previous large cohort studies of PPI users and intervention studies of PPI use for 4 weeks reported increases in bacteria from the genus Streptococcus [19, 20, 22, 23].”
InfluentialMicroorganisms with Claimed Probiotic Properties: An Overview of Recent Literature
Fijan, S. (2014) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph110504745 · Cited by 1,059 · cited 1×
“The biological effects of probiotics are strain specific [58], and whether these bacteria have probiotic features is determined by a coevolutionary relationship between the bacteria and their hosts [59].”
Proton pump inhibitors alter the composition of the gut microbiota
Jackson, M. A., Goodrich, J. K., Maxan, M.-E., Freedberg, D. E., Abrams, J. A., Poole, A. C., Sutter, J. L., Welter, D., Ley, R. E., Bell, J. T., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310861 · Cited by 895
Matsuki, T., Watanabe, K., Fujimoto, J., Miyamoto, Y., Takada, T., Matsumoto, K., Oyaizu, H., & Tanaka, R. (2002) · Applied and Environmental Microbiology · doi:10.1128/aem.68.11.5445-5451.2002 · Cited by 657
Self-citationMatsuki, T., Watanabe, K., Fujimoto, J., Takada, T., & Tanaka, R. (2004) · Applied and Environmental Microbiology · doi:10.1128/aem.70.12.7220-7228.2004 · Cited by 655
Systematic review of the risk of enteric infection in patients taking acid suppression
Leonard, J., Marshall, J. K., & Moayyedi, P. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01275.x · Cited by 633
Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson's disease
Hasegawa, S., Goto, S., Tsuji, H., Okuno, T., Asahara, T., Nomoto, K., Shibata, A., Fujisawa, Y., Minato, T., Okamoto, A., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0142164 · Cited by 523 · cited 1×
“In addition to our results, increased numbers of Lactobacillus were also observed in patients with diseases such as diabetes mellitus type 2 [36] and Parkinson’s disease [57].”
Self-citationThomas, C. M., Hong, T., van Pijkeren, J. P., Hemarajata, P., Trinh, D. V., Hu, W., Britton, R. A., Kalkum, M., & Versalovic, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031951 · Cited by 491
tana, C., umesaki, Y., imaoka, A., handa, T., kanazawa, M., & fukudo, S. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01427.x · Cited by 474 · cited 1×
“Since organic acids are produced by colonic bacteria, any alteration in gut microbiota composition may be associated with a change in organic acid composition [30].”
Sato, J., Kanazawa, A., Ikeda, F., Yoshihara, T., Goto, H., Abe, H., Komiya, K., Kawaguchi, M., Shimizu, T., Ogihara, T., et al. (2014) · Diabetes Care · doi:10.2337/dc13-2817 · Cited by 437
Self-citationThe Gastrointestinal Microbiome: Alcohol Effects on the Composition of Intestinal Microbiota
Engen, P. (2015) · Alcohol Research: Current Reviews · doi:10.35946/arcr.v37.2.07 · Cited by 436
Bacterial Translocation from the Gastrointestinal Tract
Berg, R. D. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4615-4143-1_2 · Cited by 407
Increased Incidence of Small Intestinal Bacterial Overgrowth During Proton Pump Inhibitor Therapy
Lombardo, L., Foti, M., Ruggia, O., & Chiecchio, A. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.12.022 · Cited by 350
Freedberg, D. E., Toussaint, N. C., Chen, S. P., Ratner, A. J., Whittier, S., Wang, T. C., Wang, H. H., & Abrams, J. A. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.06.043 · Cited by 322 · cited 15×
“Previous large cohort studies of PPI users and intervention studies of PPI use for 4 weeks reported increases in bacteria from the genus Streptococcus [19, 20, 22, 23].”
InfluentialSensitive Quantitative Detection of Commensal Bacteria by rRNA-Targeted Reverse Transcription-PCR
Matsuda, K., Tsuji, H., Asahara, T., Kado, Y., & Nomoto, K. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.01224-06 · Cited by 294
Self-citationOmeprazole: An Updated Review of its Pharmacology and Therapeutic Use in Acid-Related Disorders
McTavish, D., Buckley, M. M.-T., & Heel, R. C. (1991) · Drugs · doi:10.2165/00003495-199142010-00008 · Cited by 282
Wolff, T., Miller, T., & Ko, S. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-6-200903170-00009 · Cited by 263
Matsuda, K., Tsuji, H., Asahara, T., Matsumoto, K., Takada, T., & Nomoto, K. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01843-08 · Cited by 258
Self-citationGut Dysbiosis in Patients with Anorexia Nervosa
Morita, C., Tsuji, H., Hata, T., Gondo, M., Takakura, S., Kawai, K., Yoshihara, K., Ogata, K., Nomoto, K., Miyazaki, K., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0145274 · Cited by 238
Self-citationEffect of Short‐Chain Fatty Acids on the Human Colonic Mucosa in Vitro
Scheppach, W., Bartram, P., Richter, A., Richter, F., Liepold, H., Dusel, G., Hofstetter, G., Rüthlein, J., & Kasper, H. (1992) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860719201600143 · Cited by 234
Genomic and phenotypic evidence for probiotic influences of Lactobacillus gasseri on human health
Selle, K., & Klaenhammer, T. R. (2013) · FEMS Microbiology Reviews · doi:10.1111/1574-6976.12021 · Cited by 227
Kaci, G., Goudercourt, D., Dennin, V., Pot, B., Doré, J., Ehrlich, S. D., Renault, P., Blottière, H. M., Daniel, C., & Delorme, C. (2014) · Applied and Environmental Microbiology · doi:10.1128/aem.03133-13 · Cited by 221
Relationship between gastric secretion and infection.
Howden, C. W., & Hunt, R. H. (1987) · Gut · doi:10.1136/gut.28.1.96 · Cited by 208
Short chain fatty acids dilate isolated human colonic resistance arteries.
Mortensen, F. V., Nielsen, H., Mulvany, M. J., & Hessov, I. (1990) · Gut · doi:10.1136/gut.31.12.1391 · Cited by 197
The Impact of Proton Pump Inhibitors on the Human Gastrointestinal Microbiome
Freedberg, D. E., Lebwohl, B., & Abrams, J. A. (2014) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2014.08.008 · Cited by 195
Risk factors for progression of lumbar spine disc degeneration: The Chingford Study
Hassett, G., Hart, D. J., Manek, N. J., Doyle, D. V., & Spector, T. D. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11321 · Cited by 184
Ohigashi, S., Sudo, K., Kobayashi, D., Takahashi, O., Takahashi, T., Asahara, T., Nomoto, K., & Onodera, H. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2526-4 · Cited by 180
Self-citationEffect of organic acid absorption on bicarbonate transport in rat colon
Umesaki, Y., Yajima, T., Yokokura, T., & Mutai, M. (1979) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00622903 · Cited by 123
Takagi, T., Naito, Y., Inoue, R., Kashiwagi, S., Uchiyama, K., Mizushima, K., Tsuchiya, S., Okayama, T., Dohi, O., Yoshida, N., et al. (2018) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.17-78 · Cited by 121
Northeastern Ohio trauma study III: Incidence of fractures
Fife, D., & Barancik, J. I. (1985) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(85)80448-0 · Cited by 114
Omeprazole: An Update of its Pharmacology and Therapeutic Use in Acid-Related Disorders
Wilde, M. I., & McTavish, D. (1994) · Drugs · doi:10.2165/00003495-199448010-00008 · Cited by 114
Proton pump inhibitors in prevention of low-dose aspirin-associated upper gastrointestinal injuries
Mo, C. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i17.5382 · Cited by 109
Sherid, M., Samo, S., Sulaiman, S., Husein, H., Sifuentes, H., & Sridhar, S. (2016) · BMC Gastroenterology · doi:10.1186/s12876-016-0552-y · Cited by 108 · cited 1×
“However, there are several case reports demonstrating that lactobacilli caused serious infections such as bacteremia and liver abscesses in susceptible immunocompromised patients [55, 56].”
Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use
Naito, Y., Kashiwagi, K., Takagi, T., Andoh, A., & Inoue, R. (2018) · Digestion · doi:10.1159/000481813 · Cited by 107
Short-chain fatty acids stimulate motility of the canine ileum
Kamath, P. S., Hoepfner, M. T., & Phillips, S. F. (1987) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1987.253.4.g427 · Cited by 103 · cited 1×
“Organic acids have various pathophysiological effects on mucosal blood flow in the gastrointestinal tract [25], intestinal epithelial proliferation [26], intestinal motility [27], and control of the intraluminal pH [28] and are major energy sources for intestinal epithelial cells [29].”
Papizadeh, M., Rohani, M., Nahrevanian, H., Javadi, A., & Pourshafie, M. R. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.08.021 · Cited by 94
Xu, H. B., Wang, H. D., Li, C. H., Ye, S., Dong, M. S., Xia, Q. J., Zhang, A. Q., Pan, K., Ge, X. L., & Dong, J. H. (2015) · Genetics and Molecular Research · doi:10.4238/2015.july.3.25 · Cited by 89
The Effect of Proton Pump-Inhibiting Drugs on Mineral Metabolism
Insogna, K. L. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.44 · Cited by 86
Robinson, M. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02160.x · Cited by 82
Suzuki, Y., Ikeda, K., Sakuma, K., Kawai, S., Sawaki, K., Asahara, T., Takahashi, T., Tsuji, H., Nomoto, K., Nagpal, R., et al. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00847 · Cited by 77
Self-citationOtsuka, T., Sugimoto, M., Inoue, R., Ohno, M., Ban, H., Nishida, A., Inatomi, O., Takahashi, S., Naito, Y., & Andoh, A. (2017) · Gut · doi:10.1136/gutjnl-2016-313312 · Cited by 76
Varma, P., Dinesh, K. R., Menon, K. K., & Biswas, R. (2010) · Journal of Food Science · doi:10.1111/j.1750-3841.2010.01818.x · Cited by 74
Carswell, C., & Goa, K. L. (2001) · Drugs · doi:10.2165/00003495-200161150-00016 · Cited by 71
de Vos, M., De Vroey, B., Garcia, B. G., Roy, C., Kidd, F., Henrion, J., & Deltenre, P. (2013) · Liver International · doi:10.1111/liv.12210 · Cited by 67
Population structure of Streptococcus oralis
Do, T., Jolley, K. A., Maiden, M. C. J., Gilbert, S. C., Clark, D. T., Wade, W. G., & Beighton, D. (2009) · Microbiology · doi:10.1099/mic.0.027284-0 · Cited by 65
Nakajima, S., Nishiyama, Y., Yamaoka, M., Yasuoka, T., & Cho, E. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.06214.x · Cited by 63
Singh, G., & Triadafilopoulos, G. (2005) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2005.00660.x · Cited by 63
Overweight is a risk factor for both erosive and non-erosive reflux disease
Savarino, E. V., Zentilin, P., Marabotto, E., Bonfanti, D., Inferrera, S., Assandri, L., Sammito, G., Gemignani, L., Furnari, M., Dulbecco, P., et al. (2011) · Digestive and Liver Disease · doi:10.1016/j.dld.2011.07.014 · Cited by 62
Sakaguchi, S., Saito, M., Tsuji, H., Asahara, T., Takata, O., Fujimura, J., Nagata, S., Nomoto, K., & Shimizu, T. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01724-09 · Cited by 62
Self-citationTaweechotipatr, M., Iyer, C., Spinler, J. K., Versalovic, J., & Tumwasorn, S. (2009) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2009.01506.x · Cited by 54
Matsuda, K., Tsuji, H., Asahara, T., Takahashi, T., Kubota, H., Nagata, S., Yamashiro, Y., & Nomoto, K. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.07990-11 · Cited by 50
Self-citationWang, Y., Liu, C., Chen, T. ‐., Lin, Y. ‐., & Fung, C.-P. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13203 · Cited by 46
Lactobacillus: the not so friendly bacteria
Pararajasingam, A., & Uwagwu, J. (2017) · BMJ Case Reports · doi:10.1136/bcr-2016-218423 · Cited by 45
The role of the colonic flora in maintaining a healthy large bowel mucosa.
Chapman, M. (2001) · PubMed · Cited by 23
Ramamoorthy, S. L., Lee, J. K., Mintz, Y., Cullen, J., Savu, M. K., Easter, D. W., Chock, A., Mittal, R., Horgan, S., & Talamini, M. A. (2009) · Surgical Endoscopy · doi:10.1007/s00464-009-0559-3 · Cited by 16
The Role of the Colonic Flora in Maintaining a Healthy Large Bowel Mucosa
Chapman, M. (2003) · Bioscience and Microflora · doi:10.12938/bifidus1996.22.15 · Cited by 10
Zhou, S., Wang, S., Ma, Y., Tang, L., Shi, Y., Liang, B., Chen, Y., & Yu, K. (2016) · Hematology · doi:10.1080/10245332.2016.1142711 · Cited by 9
Cited by
Dysbiosis of the gut and lung microbiome has a role in asthma
Hufnagl, K., Pali-Schöll, I., Roth-Walter, F., & Jensen-Jarolim, E. (2020) · Seminars in Immunopathology · doi:10.1007/s00281-019-00775-y · Cited by 364
Derosa, L., Iebba, V., Silva, C. A. C., Piccinno, G., Wu, G., Lordello, L., Routy, B., Zhao, N., Thelemaque, C., Birebent, R., et al. (2024) · Cell · doi:10.1016/j.cell.2024.05.029 · Cited by 198
The role of oral bacteria in inflammatory bowel disease
Read, E., Curtis, M. A., & Neves, J. F. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00488-4 · Cited by 193
The microbiome and cancer for clinicians
Picardo, S. L., Coburn, B. A., & Hansen, A. R. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.06.004 · Cited by 150
Mechanisms of proton pump inhibitor‐induced hypomagnesemia
Gommers, L. M. M., Hoenderop, J. G. J., & de Baaij, J. H. F. (2022) · Acta Physiologica · doi:10.1111/apha.13846 · Cited by 167
Metadata
- Authors
- Hojo, M., Asahara, T., Nagahara, A., Takeda, T., Matsumoto, K., Ueyama, H., Matsumoto, K., Asaoka, D., Takahashi, T., Nomoto, K., Yamashiro, Y., & Watanabe, S.
- Affiliations
- Juntendo University (JP)
- Juntendo Tokyo Koto Geriatric Medical Center (JP)
- Tokyo University of Agriculture (JP)
- Corresponding author
- Hojo, Mariko
- ORCID
- Venue
- Digestive Diseases and Sciences
- Published
- 2018-05-24
- Volume
- 63
- Issue
- 11
- Pages
- 2940-2949
- ISSN
- 0163-2116 (ISSN-L)
- 1573-2568
- PMC
- PMC6182435
- OpenAlex
- W2804467228
- Cited by
- 114
- References
- 62
- Citations by year
- 2026: 11 · 2025: 12 · 2024: 12 · 2023: 15 · 2022: 11 · 2021: 28 · 2020: 15 · 2019: 8 · 2018: 1
- FWCI
- 4.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by-nc/4.0 (tdm)
- Locations
- Digestive Diseases and Sciences (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Yakult Honsha
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Medicine › Gastroenterology › Gastroesophageal reflux and treatments
- Keywords
- proton pump inhibitors, gut microbiota, reflux esophagitis, gut dysbiosis, Lactobacillus, Streptococcus, fecal pH, bacterial translocation, gastrointestinal infections, Lactobacillus gasseri, Lactobacillus fermentum, Lactobacillus reuteri, Lactobacillus ruminis
- MeSH terms
- Gastrointestinal Microbiome, Aged, Blood, Carboxylic Acids, Feces, Female, Humans, Male, Middle Aged, Proton Pump Inhibitors, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
